Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Andrew Good

1PUBLICATIONS

27CO-AUTHORS

Molecular targets

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|Oct 28, 2025

CFT1946 Is an Orally Available Brain-Penetrant BRAFV600-Mutant Degrader That Overcomes BRAF Inhibitor Resistance.

Bridget T Kreger, Yanke Liang, Nicole M Reilly

Pageof 1

Frequent Collaborators

1 joint publications

Bridget T Kreger

1 joint publications

Yanke Liang

1 joint publications

Nicole M Reilly

1 joint publications

Meghan E Spears

1 joint publications

William A Scott

1 joint publications

Jeffrey R Simard

1 joint publications

Ping Li

1 joint publications

Prasoon Chaturvedi

1 joint publications

Roman V Agafonov

1 joint publications

Jacob Stephenson

Frequent Collaborators

1 joint publications

Bridget T Kreger

1 joint publications

Yanke Liang

1 joint publications

Nicole M Reilly

1 joint publications

Meghan E Spears

Top Related Videos

<i>Ex Vivo</i> Culture of Circulating Tumor Cells in the Cerebral Spinal Fluid from Melanoma Patients to Study Melanoma-Associated Leptomeningeal Disease

<i>Ex Vivo</i> Culture of Circulating Tumor Cells in the Cerebral Spinal Fluid from Melanoma Patients to Study Melanoma-Associated Leptomeningeal Disease

Published on : Mar 29, 2024

See more related videos

Top Related Videos

<i>Ex Vivo</i> Culture of Circulating Tumor Cells in the Cerebral Spinal Fluid from Melanoma Patients to Study Melanoma-Associated Leptomeningeal Disease

<i>Ex Vivo</i> Culture of Circulating Tumor Cells in the Cerebral Spinal Fluid from Melanoma Patients to Study Melanoma-Associated Leptomeningeal Disease

Published on : Mar 29, 2024

See more related videos